Literature DB >> 22004501

Modified Jaipur block for the treatment of post-herpetic neuralgia.

Neerja Puri1.   

Abstract

Post-herpetic neuralgia means pain which occurs for longer than one to three months after the resolution of the rash of herpes zoster. We conducted a study of 30 patients having post herpetic neuralgia. All the patients were treated with modified Jaipur block consisting of local subcutaneous infiltration of 2% Xylocaine, 0.5% bupivacaine and methylprednisolone. In our study, it was seen that 20% patients had complete relief of pain after first injection, 60% patients had complete relief of pain after second injection, 10% patients had complete relief of pain after third injection, and only 10% patients did not respond to treatment. The non-responders were either old (over 60 years) or had pain lasting for more than two years.
© 2011 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004501     DOI: 10.1111/j.1365-4632.2011.5083.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   3.204


  3 in total

Review 1.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

Review 2.  Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis.

Authors:  Marshall Devor
Journal:  Pain Rep       Date:  2018-11-07

3.  Post Herpetic Neuralgia: A Retrospective Study to Evaluate Response to Modified Jaipur Block with Increased Concentration of Dexamethasone.

Authors:  Reena K Sharma; Mudita Gupta; Geeta R Tegta; Ghanshyam Verma; Ritu Rani
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.